One-step biosynthesis of α-ketoisocaproate from L-leucine by an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase from Proteus vulgaris
- PMID: 26217895
- PMCID: PMC4517468
- DOI: 10.1038/srep12614
One-step biosynthesis of α-ketoisocaproate from L-leucine by an Escherichia coli whole-cell biocatalyst expressing an L-amino acid deaminase from Proteus vulgaris
Abstract
This work aimed to develop a whole-cell biotransformation process for the production of α-ketoisocaproate from L-leucine. A recombinant Escherichia coli strain was constructed by expressing an L-amino acid deaminase from Proteus vulgaris. To enhance α-ketoisocaproate production, the reaction conditions were optimized as follows: whole-cell biocatalyst 0.8 g/L, leucine concentration 13.1 g/L, temperature 35 °C, pH 7.5, and reaction time 20 h. Under the above conditions, the α-ketoisocaproate titer reached 12.7 g/L with a leucine conversion rate of 97.8%. In addition, different leucine feeding strategies were examined to increase the α-ketoisocaproate titer. When 13.1 g/L leucine was added at 2-h intervals (from 0 to 22 h, 12 addition times), the α-ketoisocaproate titer reached 69.1 g/L, while the leucine conversion rate decreased to 50.3%. We have developed an effective process for the biotechnological production of α-ketoisocaproate that is more environmentally friendly than the traditional petrochemical synthesis approach.
Figures



















References
-
- Aparicio M. et al. Keto acid therapy in predialysis chronic kidney disease patients: final consensus. J. Renal. Nutr. 22, S22–S24 (2012). - PubMed
-
- Aparicio M. et al. Protein-restricted diets plus keto/amino acids-a valid therapeutic approach for chronic kidney disease patients. J. Renal. Nutr. 22, S1–S21 (2012). - PubMed
-
- Mou S., Li J., Yu Z., Wang Q. & Ni Z. Keto acid-supplemented low-protein diet for treatment of adult patients with hepatitis B virus infection and chronic glomerulonephritis. J. Int. Med. Res. 41, 129–137 (2013). - PubMed
-
- Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition. 26, 482–490 (2010). - PubMed
-
- Chua B., Siehl D. L. & Morgan H. E. Effect of leucine and metabolites of branched chain amino acids on protein turnover in heart. J. Biol. Chem. 254, 8358–8362 (1979). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases